Investigational Site Number : 643004

Saint Petersburg 199106

0 studies enrolling now · 8 studies all time

What they study most

Acute Coronary Syndrome, Diabetes Mellitus, Type 2, Hematological Malignancy, Hematopoietic Neoplasm, Non-small Cell Lung Cancer, Ovarian Cancer Recurrent, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies — Completed
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy — Completed
• Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine — Completed
• Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) — Completed
• Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel — Completed
• Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer — Completed
• Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure — Completed